Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats

Takayuki Yamada, Kazuwa Nakao, Hiroshi Itoh, Narito Morii, Shozo Shiono, Makoto Sakamoto, Akira Sugawara, Yoshihiko Saito, Masashi Mukoyama, Hiroshi Arai, Hiroo Imura

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effects of leumorphin, a K-agonist derived from proenkephalin B (neoendorphin and dynorphin precursor), on vasopressin secretion were studied under basal and stimulated conditions in conscious, unrestrained rats. Intracerebroventricular injection of leumorphin (60 or 600 pmol) significantly inhibited basal vasopressin secretion. The vasopressin response induced by intracerebroventricular injection of angiotensin II (100 pmol) was significantly suppressed, hi a dose-dependent fashion, by the simultaneous intracerebroventricular injection of leumorphin (6, 60, or 600 pmol). Intravenous pretreatment with naloxone (0.5 mg/kg body weight) diminished the inhibitory action of leumorphin (60 pmol) on vasopressin secretion. Moreover, naloxone (0.5 mg/kg body weight) prolonged the vasopressin secretion induced by intracerebroventricular injection of angiotensin II (100 pmol). These results indicate that leumorphin possesses a potent inhibitory effect on vasopressin secretion and that, alone or in combination with other endogenous opioid peptides, it plays an important role hi the control of vasopressin secretion.

Original languageEnglish
Pages (from-to)I-80-I-83
JournalHypertension
Volume11
Issue number2
Publication statusPublished - 1988
Externally publishedYes

Fingerprint

Vasopressins
Injections
Naloxone
Angiotensin II
Body Weight
Dynorphins
Opioid Peptides
preproenkephalin

Keywords

  • Angiotensin II
  • Naloxone
  • Opioid peptides
  • Vasopressin

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Yamada, T., Nakao, K., Itoh, H., Morii, N., Shiono, S., Sakamoto, M., ... Imura, H. (1988). Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats. Hypertension, 11(2), I-80-I-83.

Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats. / Yamada, Takayuki; Nakao, Kazuwa; Itoh, Hiroshi; Morii, Narito; Shiono, Shozo; Sakamoto, Makoto; Sugawara, Akira; Saito, Yoshihiko; Mukoyama, Masashi; Arai, Hiroshi; Imura, Hiroo.

In: Hypertension, Vol. 11, No. 2, 1988, p. I-80-I-83.

Research output: Contribution to journalArticle

Yamada, T, Nakao, K, Itoh, H, Morii, N, Shiono, S, Sakamoto, M, Sugawara, A, Saito, Y, Mukoyama, M, Arai, H & Imura, H 1988, 'Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats', Hypertension, vol. 11, no. 2, pp. I-80-I-83.
Yamada T, Nakao K, Itoh H, Morii N, Shiono S, Sakamoto M et al. Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats. Hypertension. 1988;11(2):I-80-I-83.
Yamada, Takayuki ; Nakao, Kazuwa ; Itoh, Hiroshi ; Morii, Narito ; Shiono, Shozo ; Sakamoto, Makoto ; Sugawara, Akira ; Saito, Yoshihiko ; Mukoyama, Masashi ; Arai, Hiroshi ; Imura, Hiroo. / Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats. In: Hypertension. 1988 ; Vol. 11, No. 2. pp. I-80-I-83.
@article{6e39c39827184ebc9ece64a3383de092,
title = "Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats",
abstract = "The effects of leumorphin, a K-agonist derived from proenkephalin B (neoendorphin and dynorphin precursor), on vasopressin secretion were studied under basal and stimulated conditions in conscious, unrestrained rats. Intracerebroventricular injection of leumorphin (60 or 600 pmol) significantly inhibited basal vasopressin secretion. The vasopressin response induced by intracerebroventricular injection of angiotensin II (100 pmol) was significantly suppressed, hi a dose-dependent fashion, by the simultaneous intracerebroventricular injection of leumorphin (6, 60, or 600 pmol). Intravenous pretreatment with naloxone (0.5 mg/kg body weight) diminished the inhibitory action of leumorphin (60 pmol) on vasopressin secretion. Moreover, naloxone (0.5 mg/kg body weight) prolonged the vasopressin secretion induced by intracerebroventricular injection of angiotensin II (100 pmol). These results indicate that leumorphin possesses a potent inhibitory effect on vasopressin secretion and that, alone or in combination with other endogenous opioid peptides, it plays an important role hi the control of vasopressin secretion.",
keywords = "Angiotensin II, Naloxone, Opioid peptides, Vasopressin",
author = "Takayuki Yamada and Kazuwa Nakao and Hiroshi Itoh and Narito Morii and Shozo Shiono and Makoto Sakamoto and Akira Sugawara and Yoshihiko Saito and Masashi Mukoyama and Hiroshi Arai and Hiroo Imura",
year = "1988",
language = "English",
volume = "11",
pages = "I--80--I--83",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Implication of leumorphin in inhibitory control of vasopressin secretion in conscious rats

AU - Yamada, Takayuki

AU - Nakao, Kazuwa

AU - Itoh, Hiroshi

AU - Morii, Narito

AU - Shiono, Shozo

AU - Sakamoto, Makoto

AU - Sugawara, Akira

AU - Saito, Yoshihiko

AU - Mukoyama, Masashi

AU - Arai, Hiroshi

AU - Imura, Hiroo

PY - 1988

Y1 - 1988

N2 - The effects of leumorphin, a K-agonist derived from proenkephalin B (neoendorphin and dynorphin precursor), on vasopressin secretion were studied under basal and stimulated conditions in conscious, unrestrained rats. Intracerebroventricular injection of leumorphin (60 or 600 pmol) significantly inhibited basal vasopressin secretion. The vasopressin response induced by intracerebroventricular injection of angiotensin II (100 pmol) was significantly suppressed, hi a dose-dependent fashion, by the simultaneous intracerebroventricular injection of leumorphin (6, 60, or 600 pmol). Intravenous pretreatment with naloxone (0.5 mg/kg body weight) diminished the inhibitory action of leumorphin (60 pmol) on vasopressin secretion. Moreover, naloxone (0.5 mg/kg body weight) prolonged the vasopressin secretion induced by intracerebroventricular injection of angiotensin II (100 pmol). These results indicate that leumorphin possesses a potent inhibitory effect on vasopressin secretion and that, alone or in combination with other endogenous opioid peptides, it plays an important role hi the control of vasopressin secretion.

AB - The effects of leumorphin, a K-agonist derived from proenkephalin B (neoendorphin and dynorphin precursor), on vasopressin secretion were studied under basal and stimulated conditions in conscious, unrestrained rats. Intracerebroventricular injection of leumorphin (60 or 600 pmol) significantly inhibited basal vasopressin secretion. The vasopressin response induced by intracerebroventricular injection of angiotensin II (100 pmol) was significantly suppressed, hi a dose-dependent fashion, by the simultaneous intracerebroventricular injection of leumorphin (6, 60, or 600 pmol). Intravenous pretreatment with naloxone (0.5 mg/kg body weight) diminished the inhibitory action of leumorphin (60 pmol) on vasopressin secretion. Moreover, naloxone (0.5 mg/kg body weight) prolonged the vasopressin secretion induced by intracerebroventricular injection of angiotensin II (100 pmol). These results indicate that leumorphin possesses a potent inhibitory effect on vasopressin secretion and that, alone or in combination with other endogenous opioid peptides, it plays an important role hi the control of vasopressin secretion.

KW - Angiotensin II

KW - Naloxone

KW - Opioid peptides

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0023925661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023925661&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - I-80-I-83

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -